Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
IRP1 deficiency alters mitochondrial metabolism and protects against metabolic syndrome pathologies
Wen Gu, Nicole Wilkinson, Carine Fillebeen, Darren M. Blackburn, Korin Sahinyan, Eric Bonneil, Tao Zhao, Zhi Luo, Vahab D. Soleimani, Vincent Richard, Christoph H. Borchers, Albert Koulman, Benjamin Jenkins, Bernhard Michalke, Hans Zischka, Judith Sailer, Vivek Venkataramani, Othon Iliopoulos, Gary Sweeney, Kostas Pantopoulos
Wen Gu, Nicole Wilkinson, Carine Fillebeen, Darren M. Blackburn, Korin Sahinyan, Eric Bonneil, Tao Zhao, Zhi Luo, Vahab D. Soleimani, Vincent Richard, Christoph H. Borchers, Albert Koulman, Benjamin Jenkins, Bernhard Michalke, Hans Zischka, Judith Sailer, Vivek Venkataramani, Othon Iliopoulos, Gary Sweeney, Kostas Pantopoulos
View: Text | PDF
Research Article Hepatology Metabolism

IRP1 deficiency alters mitochondrial metabolism and protects against metabolic syndrome pathologies

  • Text
  • PDF
Abstract

Iron regulatory protein 1 (IRP1) is a posttranscriptional regulator of cellular iron metabolism. In mice, loss of IRP1 causes polycythemia through translational de-repression of HIF2α mRNA, which increases renal erythropoietin production. Here, we show that Irp1–/– mice develop fasting hypoglycemia and are protected against high-fat diet–induced hyperglycemia and hepatic steatosis. Discovery-based proteomics of Irp1–/– livers revealed a mitochondrial dysfunction signature. Seahorse flux analysis in primary hepatocytes and differentiated skeletal muscle myotubes confirmed impaired respiratory capacity, with a shift from oxidative phosphorylation to glycolytic ATP production. This metabolic rewiring was associated with enhanced insulin sensitivity and increased glucose uptake in skeletal muscle. Under metabolic stress, IRP1 deficiency altered the redox balance of mitochondrial iron, resulting in inefficient energy production and accumulation of amino acids and metabolites in skeletal muscles, rendering them unavailable for hepatic gluconeogenesis. These findings identify IRP1 as a critical regulator of systemic energy homeostasis.

Authors

Wen Gu, Nicole Wilkinson, Carine Fillebeen, Darren M. Blackburn, Korin Sahinyan, Eric Bonneil, Tao Zhao, Zhi Luo, Vahab D. Soleimani, Vincent Richard, Christoph H. Borchers, Albert Koulman, Benjamin Jenkins, Bernhard Michalke, Hans Zischka, Judith Sailer, Vivek Venkataramani, Othon Iliopoulos, Gary Sweeney, Kostas Pantopoulos

×

Figure 1

Young Irp1–/– mice are hypoglycemic, and adult animals do not develop high fat diet–induced hyperglycemia.

Options: View larger image (or click on image) Download as PowerPoint
Young Irp1–/– mice are hypoglycemic, and adult animals do not develop hi...
In A, B, D, and F–L, male Irp1–/– mice and WT littermates (n = 4–8 per experimental group) were analyzed at weaning (age of 5 weeks) or following dietary interventions initiated immediately after weaning (10 weeks, unless otherwise indicated). In E, male Irp1–/–-, WT, Irp1–/– Hif2αAlb-Cre, and Hif2αAlb-Cre mice (n = 5–10 per experimental group) were analyzed at weaning. (A) Fasting (5 hours) blood glucose levels and (B) insulin tolerance test at weaning, after 4 hours’ fasting. (C) Genotyping of all Irp1+/+, Irp1+/–, and Irp1–/– littermates generated throughout this study. (D) Fasting (5 hours) blood glucose levels in littermate mice fed a control or an iron-deficient diet (IDD). (E) Oral GTT after 16 hours’ fasting. (F) GTT after 5 hours’ fasting; (G) time-dependent changes in body weight of mice fed a control or a high-fat diet (HFD); and (H) pyruvate tolerance test after 6 hours’ fasting. (I) Blood glucose levels in littermate mice fed control or HFD following fasting for 4, 6, or 16 hours. (J) GTT in littermate mice after 4 hours’ fasting at baseline, and after feeding HFD for 1 week and 10 weeks. (K and L) qPCR analysis of liver G6pc (K) and Pck1 (L) mRNA expression in non-fasted littermate mice fed control or HFD for 12 weeks. The right panels in E, F, and J show AUC; in H pairwise comparisons of data from HFD-fed WT and Irp1–/– mice at various time points. Quantitative data are presented as the mean ± SEM. Statistical analysis was performed with 2-way ANOVA except E, which was 1-way ANOVA, with Tukey’s multiple-comparison test; comparisons between 2 groups were done with 2-tailed Student’s t test. *P < 0.05, **P < 0.01, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts